Topics

The Price of Substitute Technologies.

08:00 EDT 24th September 2019 | BioPortfolio

Summary of "The Price of Substitute Technologies."

Only a small share of new drugs is truly innovative; 85% to 90% of all new health technologies have little or no advantage over existing therapeutic alternatives. Health economic evaluations can be used to induce acceptable prices for new technologies through threshold pricing.

Affiliation

Journal Details

This article was published in the following journal.

Name: Value in health regional issues
ISSN: 2212-1102
Pages: 154-158

Links

DeepDyve research library

PubMed Articles [2401 Associated PubMed Articles listed on BioPortfolio]

Provider responses to online price transparency.

Price transparency initiatives have recently emerged as a solution to the lack of health care price information available to consumers. This paper uses the staggered and nationwide diffusion of a lead...

Industrial lignin from 2G biorefineries - Assessment of availability and pricing strategies.

With a view to boost practical implementation of lignin conversion technologies, this paper assesses the availability of industrial lignin and evaluates pricing strategies applicable to multi-product ...

Osteoclasts may contribute bone substitute materials remodeling and bone formation in bone augmentation.

Bone augmentation is increasingly important in implantology. Bone substitute materials exert essential roles during bone augmentation process. However, accelerating bone substitute materials remodelin...

Price dispersion of generic medications.

Generic pharmaceuticals should have very little price dispersion. Economics' Law of One Price suggests that identical goods, in the absence of trade frictions and under conditions of free competition ...

Institutions for health care price setting and regulation: A comparative review of eight settings.

Price setting and regulation serve as instruments to control volumes of services, while providing incentives for quality, coverage, and efficiency. In recognition of its complexity, many countries hav...

Clinical Trials [859 Associated Clinical Trials listed on BioPortfolio]

Paid Price Information on Image and Procedure Ordering Rates

The investigators' study seeks to explore the impact of price information on physicians' ordering behavior and care quality. The investigators will evaluate the impact of the physician pri...

Meals-for-Moms: Experimental Grocery Store Study

This is a study about how the price of foods affects food buying choices at the grocery store. The price of foods can have a big impact on what people choose to buy and prices change over ...

Food-for-Families: Experimental Grocery Store Study

This is a study about how the price of foods affects buying choices at the grocery store. The price of foods can have a big impact on what people choose to buy and prices change over time....

Shop For Success: Experimental Grocery Store Study

The purpose of this research is to study how the price of foods affects food buying choices at the grocery store. The researchers are interested in this topic because the price of foods ca...

Fast Food Photo Study

The investigators aim to discover if people of different demographic levels are more or less attentive to changes in calorie information vs. changes in price information on a restaurant me...

Medical and Biotech [MESH] Definitions

Works consisting of lists giving the prices of items for sale, including drugs, equipment, books, etc. Price lists are less detailed than catalogs and not as long.

A strategy for purchasing health care in a manner which will obtain maximum value for the price for the purchasers of the health care and the recipients. The concept was developed primarily by Alain Enthoven of Stanford University and promulgated by the Jackson Hole Group. The strategy depends on sponsors for groups of the population to be insured. The sponsor, in some cases a health alliance, acts as an intermediary between the group and competing provider groups (accountable health plans). The competition is price-based among annual premiums for a defined, standardized benefit package. (From Slee and Slee, Health Care Reform Terms, 1993)

Delivery of therapeutic rehabilitation at a distance or offsite using telecommunication technologies.

An increase in the volume of money and credit relative to available goods resulting in a substantial and continuing rise in the general price level.

The amount that a health care institution or organization pays for its drugs. It is one component of the final price that is charged to the consumer (FEES, PHARMACEUTICAL or PRESCRIPTION FEES).

Quick Search


DeepDyve research library

Searches Linking to this Article